B

BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH

Bajaj Finserv Asset Management Limited

NAV

₹12.491

NAV as of 13 Nov 2026

-0.0390 (-0.3113%)
Returns, 3Y

—

Annualised return

AUM (FUND SIZE)

₹377 Cr

Assets Under Mgmt

SINCE INCEPTION

+12.15%

Launched 30 Dec 2024

₹1 SINCE LAUNCH

₹1.24

Indexed wealth

MAX DRAWDOWN

-15.68%

Historical peak to trough

RECOVERY TIME

8.6 mo

To previous peak

CONSISTENCY

1 positive yrs

1 negative yrs

Category

EquitySectoral/ ThematicVery High Risk

Fund Info

INF0QA701AB9Bajaj Finserv Asset Management Limited
+24.11%1Y Absolute Return
-0.31%1D
Loading NAV history…

Past performance is not an indicator of future returns.

Returns calculator comparison

Compare an illustrative investment outcome across return assumptions.

AssetProjected corpusTotal investedGainAnnual return
BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTHFund 1Y annualised return · 5Y history unavailable
₹13,62,532
₹7,32,612₹6,29,920+24.11%
EPFIllustrative annual assumption
₹8,95,132
₹7,32,612₹1,62,520+8.25%
Residential propertyIllustrative annual assumption
₹8,67,662
₹7,32,612₹1,35,050+7.00%
PPFIllustrative annual assumption
₹8,69,819
₹7,32,612₹1,37,207+7.10%
Bank fixed depositIllustrative annual assumption
₹8,56,981
₹7,32,612₹1,24,369+6.50%
GoldIllustrative annual assumption
₹8,67,662
₹7,32,612₹1,35,050+7.00%
Savings accountIllustrative annual assumption
₹7,86,827
₹7,32,612₹54,215+3.00%

Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.

Wealth multiple

₹1 became₹1.12
₹1 Lakh since launch₹1.12 Lakh
Fund age1.9 yrs

Fund information

Scheme code153157
ISININF0QA701AB9
BenchmarkBSE Healthcare TRI
CategoryEquity Scheme - Sectoral/ Thematic
Expense ratio0.90%
Exit load1% for redemption within 3 Months
Minimum SIP₹500 SIP

Return comparison

33rd / 932 in category
PeriodFundBenchmarkCategory avg
1M+197.84%——
3M+18.37%——
6M+38.00%——
1Y+24.11%—+4.16%
Since Launch+12.15%——

Risk-adjusted performance

Every measure is expanded with a plain-language reading of the latest calculated value.

Sharpe ratio

0.45

Return earned for the risk taken.

Moderate

Moderate risk-adjusted returns. The reward for risk has been average.

Sortino ratio

0.63

Return earned while limiting downside risk.

Moderate

Moderate downside risk-adjusted performance.

Standard deviation

13.54%

How much the fund’s returns fluctuate over time.

Moderate volatility

Returns can move up and down noticeably.

Beta

—

How closely the fund moves with the market.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Alpha

—

Extra return generated above the benchmark.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Treynor ratio

—

Return earned for each unit of market risk taken.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Calmar ratio

0.77

How well the fund rewarded investors relative to its biggest decline.

Good

Good return relative to the drawdowns experienced.

Information ratio

—

How consistently the fund outperformed its benchmark.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Portfolio allocation

Latest disclosed portfolio mix

Asset allocation

Allocation data has not been disclosed.

Market cap allocation

Large Cap
23.02%
Small Cap
50.89%
Mid Cap
21.84%
Unclassified
0.83%

Sector allocation

Equity exposure by sector

Healthcare
87.60%
Materials
4.30%
Consumer Staples
2.66%
Industrials
1.19%
Technology
0.83%

Top holdings

10 of 35 disclosed positions

HoldingSectorInstrument typeWeight
Divi's Laboratories LtdHealthcareEquity9.67%
Sun Pharmaceutical Industries LtdHealthcareEquity8.87%
Piramal Pharma LtdHealthcareEquity6.6%
Apollo Hospitals Enterprise LtdHealthcareEquity6.5%
Aurobindo Pharma LtdHealthcareEquity6.13%
Rubicon Research Ltd.HealthcareEquity6.01%
Torrent Pharmaceuticals LtdHealthcareEquity5.48%
Neuland Laboratories LtdHealthcareEquity4.42%
Emcure Pharmaceuticals Ltd.HealthcareEquity4.37%
Max Healthcare Institute LtdHealthcareEquity3.8%

Fund management

SI
Siddharth Chaudhary

Since 2024 · Prior to joining Bajaj Finserv Mutual Fund, he has worked with Sundaram Mutual Fund and Indian Bank.

Mr. Chaudhary is a B.Com (H) and PGDM (Securities Markets).

VI
Vinay Bafna

Since 2026 · Prior to joining Bajaj Finserv Mutual Fund, he has worked with ICICI Securities Ltd

Mr. Bafna has done MBA, Finance

BH
Bharat Hegde

Since 2026 · Prior to joining the Bajaj Finserv AMC, he was associated with Bharti AXA Life Insurance Company Limited, Motilal Oswal Financial Services Limited, SBICAP Securities Limited, and CRISIL Global Research & Analytics.

B.E (Information Science), PGDM (Finance) and CFA.

Compare similar funds

No comparable category funds are available yet.
Summary

A very high-risk equity scheme - sectoral/ thematic fund. Losses and swings stayed contained — worst fall -15.7%, volatility 13.5%. Top 10 holdings make up 62% — a handful of stocks can swing returns sharply.

Strengths
  • Losses and swings stayed contained — worst fall -15.7%, volatility 13.5%.
  • Ranks 33 of 932 in its category over 1 year.
Weaknesses
  • Top 10 holdings make up 62% — a handful of stocks can swing returns sharply.
Ideal investor
  • Needs a 5–7+ years horizon to ride out its very high risk level.
  • Good fit for SIPs — spreading purchases smooths out 13.5% volatility.
Risk drivers
  • Top 10 holdings = 62% of the portfolio.
  • Healthcare makes up 88% — trouble in that sector hits the whole fund.